![Steven Immergut](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Steven Immergut worked as Senior VP & Director-Health Information at Hill & Knowlton, Inc. Served as VP & Head-Pharmaceutical Communications at Bayer Corp.
Led Corporate Communications & Investor Relations at Global Blood Therapeutics, Inc. from 2019 to 2023.
Former positions of Steven Immergut
| Companies | Position | End |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Public Communications Contact | 01/04/2023 |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Corporate Officer/Principal | - |
Hill & Knowlton, Inc.
 Hill & Knowlton, Inc. Miscellaneous Commercial ServicesCommercial Services Provides international communications consultancy services | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Hill & Knowlton, Inc.
Hill & Knowlton, Inc. Miscellaneous Commercial ServicesCommercial Services Provides international communications consultancy services | Commercial Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
- Stock Market
- Insiders
- Steven Immergut
Choose MarketScreener 
